Mixed dyslipidemia

Papers on mixed dyslipidemia

12 papers5 new in 30 days

Monday, October 26

ESC Congress 2026 AbstractOct 26

Efficacy and safety of SYH2053 in patients with primary hypercholesterolemia or mixed dyslipidemia: a phase II, multicenter, randomized, double-blind, placebo- and active-controlled trial

Randomized trial in 156 peopleInterventions

ESC Congress 2026 AbstractOct 26

Lipid-lowering therapy use and LDL-C goal achievement in patients with hypercholesterolaemia or mixed dyslipidaemia in Hong Kong: findings from a retrospective database study

Cross-sectional study of 814,451 peopleHypercholesterolemia

ESC Congress 2026 AbstractOct 26

Real-world use of bempedoic acid in women and men: pooled 1-year follow-up data from the observational, prospective, real-world MILOS study in Austria, Belgium, Germany, Italy, and the United Kingdom

Cohort study of 3,138 peopleBempedoic acid

ESC Congress 2026 AbstractOct 26

Predicted change in 10-year cardiovascular risk one year after initiation of bempedoic acid-based therapy in the MILOS study

Cohort study of 960 peopleBempedoic acid

ESC Congress 2026 AbstractOct 26

The effects of STAtin-FENOfibrate combination therapy vs. statin monotherapy on necrotic core and plaque characteristics in non-diabetic patients with combined dyslipidemia and intermediate CAOD

Randomized trial in 79 peopleStatins

Thursday, August 13

Journal of Clinical MedicineAug 13

Artificial Intelligence in Cardiovascular Risk Prediction: An Up-to-Date Narrative Review on the Emerging Role of Lipid Profile-Based Models

From lipid-focused and multimodal data to AI-based cardiovascular applications.

ReviewCardiovascular disease

Tuesday, March 24

Journal of HypertensionMar 24

Prevalence and influencing factors of masked uncontrolled hypertension among Chinese female patients with clinically controlled hypertension

Cross-sectional study of 10,527 peopleHypertension

Monday, November 3

AHA Scientific Sessions 2025 AbstractNov 3

RNA INTERFERENCE OF ANGPTL3 VIA ZODASIRAN: A NEXT-GENERATION APPROACH FOR TREATING ATHEROGENIC DYSLIPIDEMIA

Cohort study in peopleAtherogenic dyslipidemia

Tuesday, May 12

Journal of Medicinal FoodMay 12

Effect of Berberine Plus Bezafibrate Administration on the Lipid Profile of Patients with Mixed Dyslipidemia: A Pilot Clinical Trial

Randomized trial in 36 peopleBerberine

Saturday, April 25

Journal of Cystic FibrosisApr 25

Dyslipidemia is not associated with the development of glucose intolerance or diabetes in cystic fibrosis

Study in peoplePopulations

Saturday, October 6

The American Journal of the Medical SciencesOct 6

Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study

Trial in peopleInterventions

Monday, January 1

Arzneimittel-ForschungJan 1

Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation

Non-randomized trial in 40 peopleBerberine